26N-17594-18638 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-04
Registered in v-safe
2021-01-04
Dose 1 — Pfizer-BioNTech
2021-01-04
Health check-in — day 0, dose 1
Feeling: Fair · None

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-10
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-11
Health check-in — day 7, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-11
Report sent to call center — day 7, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-01-22
Dose 2 — Pfizer-BioNTech
2021-04-07
Health check-in — 3 months, dose 1
Feeling: Fair

Adult check-in
2021-07-05
Health check-in — 6 months, dose 1
Feeling: Fair

Adult check-in
2021-10-22
Dose 3 — Pfizer-BioNTech
2022-01-04
Survey response — 12 months, dose 1
MedDRA: Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Chest congestion

MedDRA releases: 2024-11 · check-in free text available
2022-01-04
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-06
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-04	Pfizer-BioNTech
2	2021-01-22	Pfizer-BioNTech	No
3	2021-10-22	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-10	priority 2/3
2021-01-11	priority 2/3
2022-01-04	Successful 2022-01-06	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 10 — 12 months, dose 1

2022-01-04

Symptoms: Chest congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release